摘要
目的观察子宫输卵管造影术(HSG)前应用阿托品联合间苯三酚解痉镇痛的效果。方法选择2018年11月~2019年11月于台山市人民医院门诊行HSG的138例不孕症患者(输卵管246条)作为研究对象,采用随机数字表法将其分为三组。阿托品组(46例,输卵管82条)于HSG前肌注阿托品,间苯三酚组(46例,输卵管83条)于HSG前肌注间苯三酚,联合组(46例,输卵管81条)于HSG前肌注间苯三酚联合阿托品。记录三组患者的HSG检查时间、造影剂用量、疼痛程度、宫颈软化度、输卵管通畅情况,比较三组患者的不良反应总发生率。结果联合组患者的宫颈软化率为97.83%,高于间苯三酚组、阿托品组的89.13%、80.43%,间苯三酚组患者的宫颈软化率高于阿托品组,差异有统计学意义(P<0.05);联合组、间苯三酚组患者的输卵管通畅率分别为75.31%、69.88%,高于阿托品组的60.98%,差异有统计学意义(P<0.05)。联合组患者的视觉模拟评分法(VAS)评分低于间苯三酚组和阿托品组,间苯三酚组患者的VAS评分低于阿托品组,差异有统计学意义(P<0.05)。联合组、间苯三酚组患者的不良反应总发生率分别为19.57%、13.04%,均低于阿托品组的32.61%,差异有统计学意义(P<0.05)。三组患者的HSG检查时间、造影剂用量比较,差异无统计学意义(P>0.05)。结论HSG前应用阿托品联合间苯三酚可进一步软化宫颈,减轻疼痛,且不增加不良反应,建议推广应用。
Objective To observe the antispasmodic and analgesic effect of Atropine combined with Phloroglucinol before hysterosalpingography(HSG).Methods Totally 138 patients(246 fallopian tubes)with infertility who underwent HSG from November 2018 to November 2019 in Outpatient of Taishan People′s Hospital were selected as the research subjects.They were divided into three groups by the random number table method.The Atropine group(46 cases,82 fallopian tubes)was injected with Atropine intramuscularly before HSG,the Phloroglucinol group(46 cases,83 fallopian tubes)was injected with Phloroglucinol intramuscularly before HSG,and the combined group(46 cases,81 fallopian tubes)was injected with Phloroglucinol combined with Atropine intramuscularly before HSG.The HSG examination time,contrast medium dosage,pain degree,cervical softening,and fallopian tube patency of the three groups were recorded,and the total incidence of adverse reactions in the three groups was compared.Results The cervical softening rate of the combined group was 97.83%,higher than that of the Phloroglucinol group and the Atropine group accounting for 89.13%and 80.43%,respectively,the cervical softening rate of the Phloroglucinol group was higher than that of the Atropine group,and the differences were statistically significant(P<0.05).The patency rate of the fallopian tubes in the combined group and the Phloroglucinol group was 75.31%and 69.88%,both higher than that in the Atropine group accounting for 60.98%,and the differences were statistically significant(P<0.05).The score of visual analogue scale(VAS)in the combined group was lower than that in the Phloroglucinol group and the Atropine group,and the VAS score in the Phloroglucinol group was lower than that in the Atropine group,with statistical significances(P<0.05).The total incidence of adverse reactions in the combined group and Phloroglucinol group was 19.57%and 13.04%,respectively,which was lower than 32.61%in the Atropine group,and the difference was statistically significant(P<0.05).There wer
作者
容玉甜
林亮初
林晓莲
RONG Yu-tian;LIN Liang-chu;LIN Xiao-lian(Taishan People′s Hospital,Guangdong Province,Taishan 529200,China)
出处
《中国当代医药》
2021年第1期170-173,共4页
China Modern Medicine
